KLK3 and prostate cancer: rs266849 was initially identified in a GWAS using controls selected for low prostate-specific antigen (PSA) levels (<0.5 ng/ml) [4] and it has been suggested that rs266849 is a marker for circulating PSA levels rather than for prostate cancer risk [16], [17].